RecruitingNCT07459582

Accuracy of Home Lactate Meter and Accu-chek Glucometer in Patients With Glycogen Storage Disease


Sponsor

Connecticut Children's Medical Center

Enrollment

10 participants

Start Date

Mar 1, 2026

Study Type

OBSERVATIONAL

Conditions

Summary

The goal of this study is to determine if the Lactate Plus meter is accurate compared to lab lactate levels, and to determine if the Accu chek guide glucometer is accurate compared to lab serum glucose levels in patients with Glycogen Storage Disease Types Ia, Ib and XI. To determine this, patient's will have a one-time planned admission to Connecticut Children's for approximately 8 hours and receive hourly blood draws as well as finger-sticks.


Eligibility

Max Age: 60 Years

Inclusion Criteria6

  • Patients with diagnosed/confirmed (by liver biopsy or genetic testing) Glycogen Storage Disease Type Ia/Ib (ICD 10 code: E74.01) or XI (74.09).
  • For pediatric participants: Ability of child's parent/legal guardian to understand and the willingness to sign a written informed consent document
  • For adolescents: assent to participate
  • For adults: Ability to understand and the willingness to sign a written informed consent
  • Patients unable to provide consent
  • Patients who decline to be in the study

Exclusion Criteria1

  • Patients with Glycogen storage disease unspecified

Interested in this trial?

Get notified about updates and connect with the research team.

Interventions

OTHERLactate Meter

Hourly blood lactate levels

DEVICEAccu Chek

Hourly blood glucose levels


Locations(1)

Connecticut Children's

Hartford, Connecticut, United States

View Full Details on ClinicalTrials.gov

For the most up-to-date information, visit the official listing.

Visit

NCT07459582


Related Trials